Nutex Health (NUTX) Stock Price, News & Analysis

Company Overview

Nutex Health Inc. is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.

The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements. Its technology and administrative platforms are intended to help providers manage patient populations and coordinate care across healthcare settings.

Nutex Health was formed through the combination of Nutex Health and Clinigence Holdings, a transaction completed in 2022. The company is headquartered in Houston, Texas, and has operated healthcare facilities and physician networks in multiple U.S. states. Dr. Tom Vo, a physician and entrepreneur, has served as the company's chief executive officer and has been associated with its founding and development.

Key Stats

• Today's Range: $198.56 to $212.00
• 50-Day Range: $151.93 to $225.00
• 52-Week Range: $83.99 to $226.16
• Volume: 122,452 shs
• Average Volume: 167,479 shs
• Market Capitalization: $1.41 billion
• P/E Ratio: 8.09
• Dividend Yield: N/A
• Price Target: $317.50
• Consensus Rating: Moderate Buy

Nutex Health Stock Analysis - MarketRank™

Nutex Health scored higher than 74% of companies evaluated by MarketBeat, and ranked 186th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Nutex Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Nutex Health has a consensus price target of $317.50, representing about 54.0% upside from its current price of $206.15.

Amount of Analyst Coverage

Nutex Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.06%

Earnings Growth

Earnings for Nutex Health are expected to grow by 4.06% in the coming year, from $27.58 to $28.70 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nutex Health is 8.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.91.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nutex Health is 8.09, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.37.

Price to Book Value per Share Ratio

Nutex Health has a P/B Ratio of 3.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

33.01% of the float of Nutex Health has been sold short.

Short Interest Ratio / Days to Cover

Nutex Health has a short interest ratio ("days to cover") of 8.19.

Change versus previous month

Short interest in Nutex Health has recently increased by 1.33%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nutex Health does not currently pay a dividend.

Dividend Growth

Nutex Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 0.17

News Sentiment

Nutex Health has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Nutex Health this week, compared to 3 articles on an average week.

Search Interest

10 people have searched for NUTX on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.

MarketBeat Follows

6 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Nutex Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $43,493.00 in company stock.

Percentage Held by Insiders

44.68% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.32% of the stock of Nutex Health is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/13/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NASDAQ:NUTX
• CIK: 1479681
• Web: www.nutexhealth.com
• Phone: (713) 660-0557
• Fax: 631-670-6780
• Employees: 944
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Nutex Health: $317.50
• High Price Target: $325.00
• Low Price Target: $310.00
• Potential Upside/Downside: +54.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $25.47
• Trailing P/E Ratio: 8.09
• Forward P/E Ratio: 7.47
• P/E Growth: N/A
• Net Income: $70.79 million
• Net Margins: 21.25%
• Pretax Margin: 40.57%
• Return on Equity: 39.74%
• Return on Assets: 18.91%

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 5.00
• Quick Ratio: 4.96

Sales & Book Value

• Annual Sales: $846.72 million
• Price / Sales: 1.67
• Cash Flow: $12.90 per share
• Price / Cash Flow: 15.98
• Book Value: $59.88 per share
• Price / Book: 3.44

Miscellaneous

• Outstanding Shares: 6,848,000
• Free Float: 3,788,000
• Market Cap: $1.41 billion
• Optionable: Not Optionable
• Beta: 0.55